Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 21.12%
March 31, 2026 3.85%
December 31, 2025 63.52%
September 30, 2025 35.26%
June 30, 2025 28.68%
March 31, 2025 -50.44%
December 31, 2024 48.56%
September 30, 2024 40.02%
June 30, 2024 -32.84%
March 31, 2024 0.17%
December 31, 2023 42.57%
September 30, 2023 27.48%
June 30, 2023 20.24%
March 31, 2023 14.00%
December 31, 2022 41.31%
September 30, 2022 26.29%
June 30, 2022 32.60%
March 31, 2022 16.96%
December 31, 2021 -3.51%
September 30, 2021 -8.41%
June 30, 2021 28.18%
March 31, 2021 -3.21%
December 31, 2020 13.77%
September 30, 2020 10.77%
June 30, 2020 -3.57%
Date Value
March 31, 2020 -38.21%
December 31, 2019 -30.48%
September 30, 2019 -18.20%
June 30, 2019 -3.53%
March 31, 2019 -10.73%
December 31, 2018 37.54%
September 30, 2018 49.14%
June 30, 2018 48.12%
March 31, 2018 33.39%
December 31, 2017 52.58%
September 30, 2017 31.88%
June 30, 2017 52.29%
March 31, 2017 49.27%
December 31, 2016 43.86%
September 30, 2016 47.51%
June 30, 2016 60.51%
March 31, 2016 58.75%
December 31, 2015 65.26%
September 30, 2015 60.45%
June 30, 2015 54.73%
March 31, 2015 55.04%
December 31, 2014 56.31%
September 30, 2014 35.67%
June 30, 2014 70.90%
March 31, 2014 60.69%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
MedMira, Inc. -26.66%
MedX Health Corp. 27.96%
VentriPoint Diagnostics Ltd. -258.1%
Profound Medical Corp. 78.41%
VVT Med, Inc. 45.51%

Gross Profit Margin (Quarterly) Related Metrics